Clinical Advancements in the Targeted Therapies against Liver Fibrosis
Hepatic fibrosis, characterized by excessive accumulation of extracellular matrix (ECM) proteins leading to liver dysfunction, is a growing cause of mortality worldwide. Hepatocellular damage owing to liver injury leads to the release of profibrotic factors from infiltrating inflammatory cells that...
| Published in: | Mediators of Inflammation |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Online Access: | http://dx.doi.org/10.1155/2016/7629724 |